- Report
- May 2021
- 200 Pages
Global
From €3604EUR$4,175USD£3,122GBP
- Report
- January 2022
- 191 Pages
Global
From €2568EUR$2,975USD£2,225GBP
€3669EUR$4,250USD£3,178GBP
- Report
- December 2024
- 125 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- November 2024
- 173 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- March 2024
- 132 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- February 2024
- 158 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- January 2024
- 485 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- November 2023
- 67 Pages
Global
From €2547EUR$2,950USD£2,206GBP
- Report
- November 2023
- 120 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- November 2023
- 171 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- October 2023
- 33 Pages
Africa
From €2547EUR$2,950USD£2,206GBP
- Report
- October 2023
- 186 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- October 2023
- 157 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- September 2023
- 180 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- August 2023
- 336 Pages
Global
From €4014EUR$4,650USD£3,478GBP
- Report
- July 2023
Global
From €2547EUR$2,950USD£2,206GBP
- Report
- May 2023
- 51 Pages
Global
From €2158EUR$2,500USD£1,870GBP
- Report
- April 2023
- 35 Pages
Global
From €2158EUR$2,500USD£1,870GBP
- Report
- March 2023
- 64 Pages
Global
From €2158EUR$2,500USD£1,870GBP
- Report
- March 2023
- 57 Pages
Global
From €2158EUR$2,500USD£1,870GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more